We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sleep Disturbance in Lung Cancer Patients.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by University Hospital, Angers.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00187980
First Posted: September 16, 2005
Last Update Posted: September 16, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Angers
  Purpose
The aim of this study is to 1-evaluate subjectively by questionnaires and objectively by ambulatory actigraphy the quality of sleep in patients with newly diagnosed lung cancer; 2- to correlate sleep quality index with quality of life, daytime alertness, Performans status and lung cancer staging at diagnosis.

Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by University Hospital, Angers:

Estimated Enrollment: 50
Study Start Date: June 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Months and older   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Newly diagnosed lung cancer age > 18 yrs Performans status < 3 Informed consent Life expectancy > 5 months

Exclusion Criteria:

Psychiatric disease Performans status > 2 Known sleep disorder

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00187980


Contacts
Contact: Yannick Le Guen, MD 33(0)241355844 yaleguen@chu-angers.fr

Locations
France
UH Recruiting
Angers, France, 49033 cedex
Contact: Yannick Le Guen, MD    33(0)241355844    yaleguen@chu-angers.fr   
Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Yannick Le Guen University Hospital, Angers
  More Information

ClinicalTrials.gov Identifier: NCT00187980     History of Changes
Other Study ID Numbers: CP 05-02
First Submitted: September 9, 2005
First Posted: September 16, 2005
Last Update Posted: September 16, 2005
Last Verified: September 2005

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases